Skip to content

Kahlon named CMO and VP of U.S. marketing at GSK Consumer Health

Table of Contents

WARREN, N.J. – GSK Consumer Healthcare has appointed Amardeep Kahlon as its chief marketing officer and vice president of U.S. marketing. In his new role, Amardeep is responsible for all aspects of marketing in the largest Consumer Healthcare market in the world. Amardeep will report to Colin Mackenzie, region head of the Americas, and become a member of his leadership team.

Amardeep Kahlon

Amardeep was formerly the vice president and global business leader for cold and flu in the Respiratory Category, where he was responsible for the global delivery of programs and innovation to drive growth on the Theraflu Brand concept. During his time in the business, Amardeep successfully led a digital acceleration program to drive new content and digital best practices.

He also led his team to launch new innovations and communications that have accelerated Theraflu to market leading growth in priority markets. This appointment reflects not only Amardeep’s impressive business results but also his proven leadership and focus on people. Amardeep succeeds Theresa Agnew, who was appointed acting area general manager for Australia and New Zealand.

GSK Consumer Healthcare region head of the Americas Colin Mackenzie said, “I’m thrilled to have Amardeep back on our team in the US. His familiarity with our market, customers and brand teams will help ensure a smooth transition and keep us on track to deliver our KPIs for Innovation, Performance and Trust. I’m looking forward to working with him and achieving much success.”

“I’m excited to take on this new role and have the opportunity to focus on all of the market leading brands within GSK’s Consumer Healthcare division,” said Amardeep. “I’ve been part of the GSK family for many years and have always been energized by the company’s powerful and inspiring mission to help people do more, feel better and live longer. I’m looking forward to working with the talented teams and growing the business.”

Comments

Latest